Natalie M Czuczman

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.

Qiang Hu, Song Liu, M. Czuczman, 2016, Blood.

MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models

M. Czuczman, G. Deeb, F. Hernandez-Ilizaliturri, 2013, Anti-cancer drugs.